Brainstorm Cell Therapeutics Inc. Gains 32.61%
Wed, Mar 29, 2023 at 07:03 PM
Brainstorm Cell Therapeutics Inc. (BCLI:NASDAQ) jumped higher at $2.44, a gain of 32.6%. On Wed, Mar 29, 2023, BCLI:NASDAQ touched a New 2-Week High of $2.44. The stock got featured on our News Catalysts scanner on Mon, Mar 27, 2023 at 02:37 PM in the 'BIOTECH' category. From Wed, Mar 15, 2023, the stock recorded 60.00% Up Days and 54.55% Green Days
About Brainstorm Cell Therapeutics Inc. (BCLI:NASDAQ)
Brainstorm Cell Therapeutics Inc is a biotechnology company. The Company develops novel adult stem cell therapies for debilitating neurodegenerative disorders such as ALS, MS, and PD among others.
Top 10 Gainers:
- Troika Media Group Inc. (TRKA:NASDAQ), 49.5%
- Local Bounti Corporation (LOCL:NYSE), 46.86%
- G Medical Innovations Holdings Ltd. (GMVD:NASDAQ), 42.33%
- LogicMark Inc Com Par$ (New) (LGMK:NASDAQ), 39.29%
- Nexters Inc. (GDEV:NASDAQ), 38.35%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 37.5%
- CBL International Limited (BANL:NASDAQ), 35.24%
- E-Home Household Service Holdings Limited (EJH:NASDAQ), 34.45%
- Tempest Therapeutics Inc. (TPST:NASDAQ), 33.71%
- Brainstorm Cell Therapeutics Inc. (BCLI:NASDAQ), 32.61%